The evaluation of anti-breast cancer activity and safety pharmacology of the ethanol extract of Aralia elata Seem. leaves
Author:
Affiliation:
1. Institute of Chinese Medicine, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, China
2. Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China
Funder
the National Key New Drug Creation Program
Publisher
Informa UK Limited
Subject
Chemical Health and Safety,Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Pharmacology,Toxicology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/01480545.2019.1601211
Reference46 articles.
1. Awareness and current knowledge of breast cancer
2. Progress in adjuvant chemotherapy for breast cancer: an overview
3. Characterizing the human equivalent dose of herbal medicines in animal toxicity studies
4. Adjuvant systemic therapy of early stage breast cancer
5. CFDA, 2014. Technical guidelines of safety pharmacological study for Chinese medicine and natural drugs. Beijing CFDA Guidelines For the Evaluation of Drug, 3–4. Available from: http://samr.cfda.gov.cn/WS01/CL1616/101015.html
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Detailed qualitative and quantitative UHPLC-DAD-ESI-MS3 analysis of Aralia spinosa L. (Araliaceae) phytochemical profile to evaluate its potential as novel plant material for bioactive compounds acquisition using in vitro culture;Industrial Crops and Products;2024-11
2. A mini-review of isolation, purification, structural characteristics and bioactivities of polysaccharides from Aralia elata (Miq.) Seem;International Journal of Biological Macromolecules;2024-10
3. PgDDS Changes the Plant Growth of Transgenic Aralia elata and Improves the Production of Re and Rg3 in Its Leaves;International Journal of Molecular Sciences;2024-02-05
4. Spatial distribution characteristics of a Pinus tabuliformis forest in the central dry zone of Ningxia, China;Australian Forestry;2023-10-19
5. Novel archetype in cancer therapeutics: exploring prospective of phytonanocarriers;3 Biotech;2022-10-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3